Nektar Therapeutics (NKTR) Tops Q1 EPS Views
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $65.70 +7.74%
Revenue Growth %: -7.1%
Financial Fact:
Other income (expense), net: 332K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -7.1%
Financial Fact:
Other income (expense), net: 332K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of $0.25, $0.65 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $108.8 million versus the consensus estimate of $20.2 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- MP Materials seen largely insulated after China export-control move
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
